iLIVER Open Access Editor-in-Chief: Jiahong Dong
Home iLIVER All Issues Volume 1 Issue 1
Volume 1 Issue 1, March 2022
Cover
Cover
Contents(PDF)
PP. 1-80
|
12 articles
Previous Issue
|
Next Issue
Editorial | Open Access
Prometheus' revelation: Deciphering the mysteries of the liver, towards a shared healthful future
Jiahong Dong
Published: 12 April 2022
2022, 1(1): 1-2
Review | Open Access
Liver transplantation for malignant liver tumors
Richard X. Sousa Da Silva, Beat Muellhaupt, Philipp Dutkowski, Pierre-Alain Clavien
Published: 18 April 2022
2022, 1(1): 3-11
Review | Open Access
Perihilar cholangiocarcinoma: a surgeon's perspective
Masato Nagino
Published: 05 April 2022
2022, 1(1): 12-24
Original Article | Open Access
Associating liver partition and portal vein ligation for staged hepatectomy ​for colorectal liver metastasis: a single-center experience
Yuanfei Peng, Feiyu Chen, Zheng Wang, [...], Xiaoying Wang, Yinghong Shi, Zhenbing Ding, Yongsheng Xiao, Kang Song, Lei Yu, Jie Hu, Min Tang, Zhaoyou Tang, Jia Fan, Jian Zhou << Fewer
Published: 09 March 2022
2022, 1(1): 25-29
Original Article | Open Access
Glycemic control predicts the risk of hepatic fibrosis in biopsy-proven NAFLD: a possible mediating role for leukemia inhibitory factor?
Feng Gong, Kenneth I. Zheng, Liang-Jie Tang, [...], Gang Li, Rafael S. Rios, Ou-Yang Huang, Yang-Yang Li, Christopher D. Byrne, Giovanni Targher, Man Mi, Na He, Hong-Lei Ma, Ming-Hua Zheng << Fewer
Published: 07 March 2022
2022, 1(1): 30-34
Original Article | Open Access
Exploratory study of microparticle transcatheter arterial chemoembolization combined with resection for huge hepatocellular carcinoma
Ying Liu, Yaqin Wang, Zhanqi Wei, [...], Tianxiao Wang, Shizhong Yang, Canhong Xiang, Xuedong Wang, Lei Gong, Jiahong Dong, Qian Lu, Yuewei Zhang << Fewer
Published: 07 March 2022
2022, 1(1): 35-42
Review | Open Access
Application of immune checkpoint inhibitors in hepatobiliary cancers
Jiajia Yuan, Lingxiao Xu, Jun Zhou, Lin Shen
Published: 17 March 2022
2022, 1(1): 43-48
Review | Open Access
Advances in artificial intelligence techniques drive the application of radiomics in the clinical research of hepatocellular carcinoma
Jingwei Wei, Meng Niu, Ouyang Yabo, [...], Yu Zhou, Xiaoke Ma, Xue Yang, Hanyu Jiang, Hui Hui, Hongyi Cao, Binwei Duan, Hongjun Li, Dawei Ding, Jie Tian << Fewer
Published: 10 March 2022
2022, 1(1): 49-54
Review | Open Access
Aspirin in hepatocellular carcinoma: Is it an out-of-date or promising treatment?
Xun Qiu, Fengqiang Gao, Kai Wang, [...], Zhensheng Zhang, Chuxiao Shao, Xiao Xu << Fewer
Published: 28 March 2022
2022, 1(1): 55-64
Review | Open Access
The pathophysiological mechanism between hypopituitarism and nonalcoholic fatty liver disease
Xinhe Zhang, Haoyu Tian, Yiling Li
Published: 10 March 2022
2022, 1(1): 65-71
Short Communication | Open Access
Ascorbic acid ameliorates isoniazid-rifampicin-induced hepatocellular damage in rats
Shubham Patel, Aman Chaturvedi, Nazneen Dubey, [...], Abhishek Shrivastava, Aditya Ganeshpurkar << Fewer
Published: 10 March 2022
2022, 1(1): 72-77
Short Communication | Open Access
Tumor-immune Co-evolution in hepatocellular carcinoma and its implication for immunotherapy resistance
Zhiyuan Fang, Huayu Yang, Yilei Mao
Published: 09 March 2022
2022, 1(1): 78-80